Sprout now stands alongside global powerhouses like Novo Nordisk and Genentech, a reflection of both its operating performance and its role in expanding the boundaries of modern healthcare. "We built this company to challenge a system that told...
over-ordering, and allows pharmacies to better match inventory to demand – especially when space is limited. Product Information YARAL Pharma’s Diclofenac Epolamine Topical System 1.3% is a nonsteroidal anti-inflammatory drug (NSAID) and is...
treatment to patients in Europe and other international markets. CE Marking, supported by an EU Declaration of Conformity and independently assessed by a Notified Body, represents SQ Innovation's formal declaration that the Company's Infusor for...
into VA and DoD systems is a meaningful step toward changing that." Rapid Nexus is advancing its broader technology platform, including NerveStim™ and Hemastyl®, through the FDA's breakthrough device designation pathway for chronic wound and...
plaque psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis.8,9 U.S. Indications and Important Safety Information about SKYRIZI® (risankizumab-rzaa)8 SKYRIZI is a prescription medicine used to treat adults with: moderate to severe...
areas of pain management, infectious disease, ophthalmology, oncology, respiratory and central nervous system. For more information please visit, www.mundipharma.com
independence in individual patients. We look forward to further evaluating CK0801 as a potentially non-toxic, transformative and curative therapy that can bring meaningful improvements in patient lives" CK0801 is designed to act, in effect, as an...
its proprietary Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD) and Ultra-Long-Acting Platform (ULAP) technologies as well as Peptide Oral Transport ENhancement Technology (POTENT), Ascletis has developed multiple drug...
prospective evaluation of TPX-100 as a potential modifier of structural disease progression. These findings also may inform patient stratification strategies in future clinical trials. In addition, they support further evaluation of femoral...
into essential laboratory tools. Mitchell-Wang is pursuing his Ph.D. at MIT, where he developed a technology that transforms standard microscopes into nanoimaging platforms by magnifying biological samples 20-fold. The method has since been adopted...
options for accessing Eliquis — a medicine relied upon by millions of Americans daily — to the popular Cost Plus Drugs platform,” said Adam Lenkowsky, chief commercial officer, Bristol Myers Squibb. “This new collaboration is grounded in a shared...
quality of life and commonly develop with traditional CAH treatment regimens. The two-year findings provide important information on the durable benefit of treatment with CRENESSITY. Providers can confidently incorporate this additional knowledge...
(FTC). Co-administration with these drugs may decrease the effectiveness of IDVYNSO. See additional selected safety information on the following pages. IDVYNSO (pronounced ihd-VIHN-soh) will be available in pharmacies after May 11. “Advances in HIV...
respectively. About Orthogon Therapeutics: Orthogon is a polyomavirus-focused biotech built on a proprietary discovery platform that fuses structure-based drug design with deep biophysical interrogation of viral proteins, unlocking targets long...
research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, please visit www.avantorsciences.com
include an increased weight capacity of up to 650 pounds5 to accommodate a broader range of patient sizes, a high performance lithium‑ion battery6 that delivers a longer lifespan compared to traditional lead acid batteries and a lower minimum table...
patients can now access Foundayo™ (orforglipron) – Eli Lilly Company's newest oral GLP-1 innovation – on the Ro platform, adding to Ro's already comprehensive formulary of FDA-approved GLP-1s. Foundayo™ is a once daily oral treatment for adults...
develop and manufacture high-quality products while maintaining long-term partnerships across the value chain. For more information please visit, www.dexcel-pharma-usa.com
continuous, noninvasive visibility into patients' blood pressure. The module delivers real-time, beat-to-beat arterial waveform data from a noninvasive finger cuff directly to compatible multiparameter patient monitors, helping clinicians close...
Dr. Singal will lead clinical strategy and development as the company advances its initial pipeline focused on transforming care for patients with chronic liver diseases. “Amit is one of the world’s leading authorities on chronic liver disease...
